XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Capital in excess of par value
Treasury stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2019     75,300,000          
Beginning balance (in shares) at Dec. 31, 2019         1,200,000      
Beginning balance at Dec. 31, 2019 $ 1,573.2 $ (0.1) $ 18.8 $ 272.7 $ (118.1) $ 1,549.4 $ (0.1) $ (149.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 346.2         346.2    
Activity related to stock-based compensation (in shares)         (700,000)      
Activity related to stock-based compensation 60.5     (5.4) $ 65.9      
Shares purchased under share repurchase program (in shares)         800,000      
Shares purchased under share repurchase program (115.5)       $ (115.5)      
Dividends declared (48.8)         (48.8)    
Other comprehensive income, net of tax 39.0             39.0
Ending balance (in shares) at Dec. 31, 2020     75,300,000          
Ending balance (in shares) at Dec. 31, 2020         1,300,000      
Ending balance at Dec. 31, 2020 1,854.5   $ 18.8 267.3 $ (167.7) 1,846.7   (110.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 661.8         661.8    
Activity related to stock-based compensation (in shares)         (700,000)      
Activity related to stock-based compensation 57.0     (18.3) $ 75.3      
Shares purchased under share repurchase program (in shares)         500,000      
Shares purchased under share repurchase program (137.1)       $ (137.1)      
Dividends declared (51.8)         (51.8)    
Other comprehensive income, net of tax $ (49.0)             (49.0)
Ending balance (in shares) at Dec. 31, 2021     75,300,000          
Ending balance (in shares) at Dec. 31, 2021 1,100,000       1,100,000      
Ending balance at Dec. 31, 2021 $ 2,335.4   $ 18.8 249.0 $ (229.5) 2,456.7   (159.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 585.9         585.9    
Activity related to stock-based compensation (in shares)         (500,000)      
Activity related to stock-based compensation $ 44.6     (16.8) $ 61.4      
Shares purchased under share repurchase program (in shares) 563,334       600,000      
Shares purchased under share repurchase program $ (202.8)       $ (202.8)      
Dividends declared (54.8)         (54.8)    
Other comprehensive income, net of tax $ (23.4)             (23.4)
Ending balance (in shares) at Dec. 31, 2022     75,300,000          
Ending balance (in shares) at Dec. 31, 2022 1,200,000       1,200,000      
Ending balance at Dec. 31, 2022 $ 2,684.9   $ 18.8 $ 232.2 $ (370.9) $ 2,987.8   $ (183.0)